Company intelligence / Profile preview

Den norske Eterfabrikk

Oslo, Norway

Ownership: Private
Development stage: Other

Overview

Den norske Eterfabrikk (DnE) is a historic Norwegian pharmaceutical manufacturer founded in 1900, originally established to produce diethyl ether for medical anesthesia. Over its long history, the company evolved from a specialized ether producer into a contract manufacturing organization (CMO) providing high-purity chemical synthesis and bottling services for the pharmaceutical and industrial sectors. In 2016, the company was acquired by the Norwegian CDMO Curida, which integrated DnE's specialized capabilities into its broader service offering. The company is particularly noted for its expertise in handling hazardous chemical processes and producing pharmaceutical-grade solvents.

Therapeutic areas: Other
Modalities: Small molecule
Industry: Contract Manufacturing Organization

Beyond the preview

Go deeper on Den norske Eterfabrikk.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Den norske Eterfabrikk.

Explore the full profile